Thyroid Function Panel - Automated Chemiluminescence Immunoassay Solution-Reagent package-Shanghai pinnaclesdx Medical Technology Co., Ltd.

产品中心

Unmanned laboratory solution
PINNACLES i-Lab

Unattended

> Intelligent sorting > Robots (Transport/Assistant) > DMP > Pneumatic > Blood collection - labeling preparation tube

Super Automation System

> Inpeco FlexLab X > P-Cell

Automation System

> S-LAS 8000/9000 > S-LAS 6000

Immunologic Diagnostics

> i6800 > i2000 > i1200 > Reagent package

Clinical Chemistry Diagnostics

> c2800 > c1800 > Reagent menu

Specific Protein Diagnosis

> PY480 > sp280

Molecular Diagnostics

> Molecular detection of drug resistance genes

Thyroid Function Panel - Automated Chemiluminescence Immunoassay Solution

Comprehensive

Up to 11 Parameters

Reliability

Excellent correlation with leading brands

Fast

Throughput up to 600 tests/hour

Clinical application

《Guidelines for the Use of Laboratory Testing in the Diagnosis and Management of Thyroid Disorders》

Clinical Significance of rT3:

Hyperthyroidism: Serum rT3 is typically elevated, paralleling increases in T4 and T3. In some cases, elevated rT3 may be the earliest detectable abnormality in initial or recurrent hyperthyroidism.

Hypothyroidism: Serum rT3 is decreased. Measurement of rT3 aids in distinguishing primary

Hypothyroidism from the euthyroid sick syndrome (non-thyroidal illness syndrome, NTIS). NTIS: Elevated serum rT3 with a reduced T3/rT3 ratio is characteristic of systemic illnesses such as acute myocardial infarction, liver cirrhosis, diabetes mellitus, uremia, and critical illness. This pattern serves as a valuable marker for assessing disease severity, monitoring therapeutic response, and predicting prognosis.

《Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis in China》

Recommendation 3-3: The third-generation TRAb assay can be used for the etiological differentiation of thyrotoxicosis and the diagnosis of Graves' disease hyperthyroidism. (Strong recommendation)

《Expert Consensus on Diagnosis and Treatment for Elderly with Thyroid Diseases in China(2021)》

Thyroid‐stimulating hormone receptor antibody (TRAb) is a crucial marker of Graves' disease. TRAb is positive in approximately 60%–90% of patients with first‐onset Graves' disease. TRAb can also be positive in patients with Graves' ophthalmopathy with normal thyroid function. In addition, TRAb has certain significance in predicting recurrence of hyperthyroidism after withdrawal of antithyroid drug therapy

Performance

Information

NO.	Name	Short name	Sample types	Linear range	Specification(Servings/Box)	Registration Number
1	Thyroid-stimulating hormone	TSH	serum and plasma	0.01~100.00μlU/mL	2x50、2x100	Guangdong Equipment Registration 20222402052
2	Triiodothyronine	T3	serum and plasma	0.20~6.51ng/mL	2x50、2x100	Guangdong Equipment Registration 20222402066
3	Thyroxine	T4	serum and plasma	5.00~248.00ng/mL	2x50、2x100	Guangdong Equipment Registration 20222402054
4	Free Triiodothyronine	FT3	serum and plasma	1.35~ 50.00pmol/L	2x50、2x100	Guangdong Equipment Registration 20232400535
5	Free Thyroxine	FT4	serum and plasma	3.86~100.00pmol/L	2x50、2x100	Guangdong Equipment Registration 20222402053
6	Reverse triiodothyronine	rT3	serum	0.20~10.00ng/mL	2x50	Guangdong Equipment Registration 20232401634
7	Thyrotropin receptor au-toantibodies	Anti-TSHR	serum	0.80~40.00IU/L	2x50	Guangdong Equipment Registration 20232401942
8	Thyroid Peroxidase Antibodies	Anti-TPO	serum and plasma	1.00~1000.00IU/mL	2x50	Guangdong Equipment Registration 20232401963
9	Anti-thyroglobulin antibodies	Anti-Tg	serum and plasma	1.00~1000.001U/mL	2x50	Guangdong Equipment Registration 20232401964
10	Thyroglobulin Antibodies	Tg	serum and plasma	0.20~ 500ng/mL	2x50	Guangdong Equipment Registration 20232401940
11	Calcitonin	CT	serum and plasma	0.50~2000pg/ml	2x50	Guangdong Equipment Registration 20232401885